India to Taiwan: Semaglutide Export Trade Route

The India to Taiwan Semaglutide corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $182.0K USD. The route is dominated by VINAYAK PHARMA CORP, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's semaglutide manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $3.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with semaglutide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 30.3%, placing it at rank #12 among India's top semaglutide export destinations globally.

On the import side, key buyers of Indian semaglutide in Taiwan include TO THE-, TO THE MANAGER- , GLOBAL INTERNATIONAL LOGISTICS LIMITED and 5 others. TO THE- is the single largest importer with 13 shipments valued at $58.7K USD.

India's semaglutide exports to Taiwan are driven primarily by a handful of large-scale manufacturers. VINAYAK PHARMA CORP with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Taiwan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VINAYAK PHARMA CORP, GMSANJIVANI LLP , GMSANJIVANI LLP — together account for 100% of total trade value on this route. The average shipment value of $3.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as rybelsus 3mg (semaglutide) (10 tab) and contain medicines harmless pharmaceutical products - semaglutide (rybelsus-14 ), suggesting that buyers in Taiwan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE- is the largest importer with 13 shipments worth $58.7K USD — representing 32% of all semaglutide imports from India on this route. A total of 8 buyers are active on this corridor.